News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. and Iranian delegations are meeting in heavily secured Islamabad's Serena Hotel for mediated talks toward de-escalation.
  • Gasoline and diesel prices hit highs not seen since early 2022, forcing households and fleets to cut miles and costs.
  • Americans are split over U.S. strikes on Iran, with many worried about prolonged deployment and higher fuel costs.
  • Trump said fleets of empty oil tankers are heading to the U.S. to load crude, spotlighting energy logistics.
  • BioNTech and DualityBio reported a nearly 48% response rate in Phase 2 data for trastuzumab pamirtecan in endometrial cancer.
  • Chinese companies are redirecting investment in Brazil from large energy projects to consumer-facing businesses and EV-related services.
  • Marvell secured a $2 billion strategic investment and is being pitched as a tactical long for AI data-center buildout.

Latest Articles

Barclays Cuts Hinge Health Price Target to $52, Keeps Overweight Rating

Barclays Cuts Hinge Health Price Target to $52, Keeps Overweight Rating

Barclays lowered its 12-month price target on Hinge Health Inc (HNGE) to $52 from $60 while retaining an Overweight rating. The firm cited stronger billings driven by higher engagement and expanded yield, alongside margin gains and ongoing investments into product rollouts. Hinge Health reported a solid Q4 beat and robust revenue growth; several ot…

Citizens Upholds Market Outperform on Amentum, Citing Scale from Merger and Exposure to National Security Priorities

Citizens Upholds Market Outperform on Amentum, Citing Scale from Merger and Exposure to National Security Priorities

Citizens has maintained its Market Outperform rating and $40.00 price objective on Amentum Holdings Inc. (AMTM), pointing to the company's scale following a transformative merger, attractive valuation, and alignment with federal national security priorities. Amentum reported a Q1 2026 earnings beat and robust revenue, but the stock moved lower in p…

Evercore ISI Increases Advance Auto Parts Price Target Ahead of Q4 Report

Evercore ISI Increases Advance Auto Parts Price Target Ahead of Q4 Report

Evercore ISI raised its price target on Advance Auto Parts to $60 from $56 and kept an In Line rating ahead of the company’s fourth-quarter earnings release scheduled for this Friday before market open. The firm points to a late-quarter sales uplift and solid January trends that could produce modest upside to consensus, while noting leverage and ma…

BofA Raises Gilead Price Target to $162 After HIV Franchise Outperformance

BofA Raises Gilead Price Target to $162 After HIV Franchise Outperformance

BofA Securities increased its price target on Gilead Sciences to $162 from $154 and kept a Buy rating after the company reported robust fourth-quarter product revenue, led by the HIV portfolio. Management signaled macro headwinds are largely behind it and guided for continued mid-single-digit growth in core franchises, while Needham also raised its…